Fusion CX IPO Day 2: GMP ₹28
Welcome back to our daily deep dive into the Fusion CX IPO! It’s Day 2 of the subscription period, and we’re here to give you the latest rundown. As of now, the subscription figures are still at a standstill, showing 0x across all categories. This might seem quiet, but let’s break down what it really means for potential investors.
| Date | GMP | Est. Listing |
|---|---|---|
| 21 Oct | +₹13 | ₹302 |
| 20 Oct | +₹20 | ₹309 |
| 19 Oct | +₹18 | ₹307 |
| 18 Oct | +₹19 | ₹308 |
| 17 Oct | +₹13 | ₹302 |
Subscription Status
The subscription numbers for Fusion CX on Day 2 are currently reflecting zero interest across the board: Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This is quite unusual, especially on the second day of an IPO. Typically, by Day 2, we’d expect to see at least some initial traction, particularly from retail investors. The absence of any subscriptions could be due to a few reasons. Perhaps investors are waiting for the final day to gauge overall sentiment, or they might be analyzing the company’s fundamentals more closely before committing. The QIB and NII categories also showing 0x suggests that the big players and high-net-worth individuals are holding back for now. This lack of early momentum is something to keep an eye on, as it could indicate caution among a broader investor base.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 5.99x | |
| NII / HNI | 4.73x | |
| QIB | 4.21x | |
| Total | 5.99x |
GMP Update
Now, let’s talk Grey Market Premium (GMP). The current GMP for Fusion CX stands steady at ₹28. Yesterday, it was also at ₹28. This stability, while not showing an increase, is not necessarily a negative sign. It suggests that the market sentiment for Fusion CX remains consistent. At an issue price of ₹289, a GMP of ₹28 translates to an expected listing price of around ₹317 (₹289 + ₹28). This indicates a potential listing gain of approximately 9.69%. While not a spectacular jump, a positive GMP is always encouraging. It signals that there’s some demand in the unlisted market, reflecting a belief that the stock might trade higher on its debut. The fact that it hasn’t dipped is a good sign, but the lack of an upward trend might be mirroring the muted subscription activity we’re seeing.
Should You Apply?
So, the big question: should you be applying for Fusion CX? The current subscription data is, frankly, a bit perplexing. A 0x subscription on Day 2 is uncommon and could make some investors hesitant. However, the steady GMP of ₹28 offers a glimmer of optimism, suggesting a potential listing gain. It’s a bit of a mixed bag. For retail investors, who can apply with a lot size of 51 shares, the potential listing gain of around ₹1,428 (51 shares * ₹28 GMP) might be attractive, especially if they’re looking for a short-term play. That said, it’s crucial to remember that GMP is an indicator, not a guarantee, and it can fluctuate. SEBI registered investment advisors often recommend looking beyond just GMP and considering the company’s long-term prospects, its financials, and the overall market conditions. Fusion CX is expected to list on the NSE Mainboard between 2026-10-14 and 2026-10-16. The bottom line is that if you’re considering applying, do your homework. Understand the business, analyze the risks, and don’t rely solely on the GMP. For more in-depth analysis and all the details you need, you can View Full Fusion CX IPO Details.